Editas Medicine to Participate in Investor Conferences in October
October 03 2017 - 8:00AM
Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing
company, today announced that management will participate in two
upcoming investor conferences in New York in October. Details
are as follows:
Chardan Gene Therapy ConferenceTuesday, October
10
- Manufacturing Panel | 12:15 p.m. ET
- Fireside Chat | 3:45 p.m. ET
Jefferies Gene Technology Investor
SummitThursday, October 12
- Presentation | 1:20 p.m. ET
A live webcast of the events will be available on the Investors
& Media section of the Editas Medicine website at
www.editasmedicine.com. An archived replay will be available for
approximately 30 days following the
events.
About Editas MedicineEditas Medicine is a leading
genome editing company dedicated to treating patients with
genetically-defined diseases by correcting their disease-causing
genes. The company was founded by world leaders in genome
editing, and its mission is to translate the promise of genome
editing science into a broad class of transformative genomic
medicines to benefit the greatest number of patients.
Media Contact Cristi Barnett
 Editas Medicine,
Inc.(617) 401-0113cristi.barnett@editasmed.com
Investor ContactMark MullikinEditas Medicine,
Inc.(617) 401-9083mark.mullikin@editasmed.com
Editas Medicine (NASDAQ:EDIT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Editas Medicine (NASDAQ:EDIT)
Historical Stock Chart
From Sep 2023 to Sep 2024